ICAAC 52nd (2012)

Title
In vitro activity of Isavuconazole against a worldwide collection of 237 Aspergillus terreus isolates and compared with 7 other Aspergillus active antifungal drugs tested with EUCAST and CLSI methodology (click for details)
In Vitro Activity of Isavuconazole Against Cryptococcus Isolates – A Pooled Analysis of 3 Studies (click for details)
Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of CYP3A4 Substrate Midazolam in Healthy Volunteers (click for details)
Isavuconazole (ISA) Pharmacodynamic (PD) Target Determination for C. albicans (CA) in an in vivo Neutropenic Murine Model of Invasive Candidiasis (IC) (click for details)
Species Distribution and Susceptibility Profile of Yeasts Isolated from Blood Cultures: Preliminary Results of a Multicenter Study for Latin America (click for details)
Environmental Variables Associated with an Increased Risk of Invasive Aspergillosis (click for details)
Prophylactic Efficacy of Liposomal Amphotericin B (LAmB) in a New Murine Model of Recurrent Pulmonary Aspergillosis Following Airborne Exposure to Aspregillus fumigatus in Immunosuppressed Mice (click for details)
Effect of Statin Use on the Outcomes of Adults with Candidemia (click for details)
Application Of The 2008 Definitions For Invasive Fungal Diseases To The Voriconazole vs Amphotericin B For Therapy Of Invasive Aspergillosis Trial. A Collaborative EORTC / MSG Study (MSG 05) (click for details)
Candidemia In Internal Medicine Wards (iIMW): Epidemiology, Time to Initiate Antifungal Treatment and Outcome (click for details)

Pages

Subscribe to ICAAC 52nd (2012)